Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110595433 | 11059543 | 3 | F | 20150122 | 20160810 | 20150423 | 20160812 | EXP | CN-AMGEN-CHNCT2015006757 | AMGEN | 76.00 | YR | E | M | Y | 71.00000 | KG | 20160812 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110595433 | 11059543 | 1 | PS | carfilzomib | CARFILZOMIB | 1 | Intravenous (not otherwise specified) | 20 MG/M2, PER CHEMO REGIM | 202714 | 20 | MG/M**2 | INTRAVENOUS INFUSION | |||||||
| 110595433 | 11059543 | 2 | SS | melphalan | MELPHALAN | 1 | Oral | 10 MG, PER CHEMO REGIM | 0 | 10 | MG | TABLET | |||||||
| 110595433 | 11059543 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 110 MG, PER CHEMO REGIM | 0 | 110 | MG | TABLET | |||||||
| 110595433 | 11059543 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 20-120 MG, AS NECESSARY DAILY | 240 | MG | 0 | ||||||||
| 110595433 | 11059543 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 240 | MG | 0 | ||||||||||
| 110595433 | 11059543 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 240 | MG | 0 | ||||||||||
| 110595433 | 11059543 | 7 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | 1 G-100 ML, BID AND QD | 0 | TABLET | ||||||||||
| 110595433 | 11059543 | 8 | C | ALDEHYDES AND DERIVATIVES | 2 | Oral | 5-10 G, QD | 10 | G | 0 | QD | ||||||||
| 110595433 | 11059543 | 9 | C | CHENG RUI | 2 | Other | 1 OTHER, QD | 0 | QD | ||||||||||
| 110595433 | 11059543 | 10 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 10 MG, TID | 90 | MG | 0 | 10 | MG | TID | |||||
| 110595433 | 11059543 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Intravenous (not otherwise specified) | 40 MG, QD | 120 | MG | 0 | 40 | MG | QD | |||||
| 110595433 | 11059543 | 12 | C | GRANISETRON HYDROCHLORIDE. | GRANISETRON HYDROCHLORIDE | 1 | Oral | 1 MG, AS NECESSARY | 0 | 1 | MG | ||||||||
| 110595433 | 11059543 | 13 | C | GRANISETRON HYDROCHLORIDE. | GRANISETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 110595433 | 11059543 | 14 | C | CETYLPYRIDINIUM CHLORIDE. | CETYLPYRIDINIUM CHLORIDE | 1 | Topical | 240 ML, AS NECESSARY | 0 | 240 | ML | ||||||||
| 110595433 | 11059543 | 15 | C | INSULIN INJECTION | INSULIN NOS | 1 | Subcutaneous | 4 IU, QD | 8 | IU | 0 | 4 | IU | QD | |||||
| 110595433 | 11059543 | 16 | C | GLUCOSE | DEXTROSE | 1 | Intravenous (not otherwise specified) | 50-100 ML, AS NECESSARY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110595433 | 11059543 | 1 | Plasma cell myeloma |
| 110595433 | 11059543 | 2 | Plasma cell myeloma |
| 110595433 | 11059543 | 3 | Plasma cell myeloma |
| 110595433 | 11059543 | 4 | Renal failure |
| 110595433 | 11059543 | 5 | Oliguria |
| 110595433 | 11059543 | 6 | Polyuria |
| 110595433 | 11059543 | 7 | Urine abnormality |
| 110595433 | 11059543 | 8 | Azotaemia |
| 110595433 | 11059543 | 9 | Intestinal obstruction |
| 110595433 | 11059543 | 10 | Prophylaxis |
| 110595433 | 11059543 | 11 | Prophylaxis |
| 110595433 | 11059543 | 12 | Nausea |
| 110595433 | 11059543 | 13 | Vomiting |
| 110595433 | 11059543 | 14 | Dry mouth |
| 110595433 | 11059543 | 15 | Blood glucose decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110595433 | 11059543 | DE |
| 110595433 | 11059543 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110595433 | 11059543 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110595433 | 11059543 | 1 | 20150120 | 20150121 | 0 | |
| 110595433 | 11059543 | 2 | 20150120 | 20150121 | 0 | |
| 110595433 | 11059543 | 3 | 20150120 | 20150121 | 0 | |
| 110595433 | 11059543 | 4 | 20150119 | 20150121 | 0 | |
| 110595433 | 11059543 | 7 | 20150119 | 20150122 | 0 | |
| 110595433 | 11059543 | 8 | 20150119 | 20150123 | 0 | |
| 110595433 | 11059543 | 9 | 20150119 | 20150119 | 0 | |
| 110595433 | 11059543 | 10 | 20150120 | 20150123 | 0 | |
| 110595433 | 11059543 | 11 | 20150120 | 20150123 | 0 | |
| 110595433 | 11059543 | 12 | 20150120 | 20150120 | 0 | |
| 110595433 | 11059543 | 14 | 20150120 | 20150120 | 0 | |
| 110595433 | 11059543 | 15 | 20150121 | 20150122 | 0 | |
| 110595433 | 11059543 | 16 | 20150120 | 20150121 | 0 |